Techniker Krankenkasse

Germany's largest health insurance company, the Techniker Krankenkasse, is a participant in the collaborative project and serves as a significant stakeholder for the clinical dissemination of molecular ultrasound. Following the success of this study, the TK will be involved in planning further and larger studies to confirm the preliminary results and ultimately support the integration of the procedure into standard care.